262 related articles for article (PubMed ID: 10810776)
1. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy.
Kuhn H; Gietzen FH; Leuner C; Schäfers M; Schober O; Strunk-Müller C; Obergassel L; Freick M; Gockel B; Lieder F; Raute-Kreinsen U
Z Kardiol; 2000; 89 Suppl 4():IV41-54. PubMed ID: 10810776
[TBL] [Abstract][Full Text] [Related]
2. [Transcoronary ablation of septal hypertrophy (TASH): a 5-year experience].
Kuhn H
Z Kardiol; 2000 Jun; 89(6):559-64. PubMed ID: 10929441
[TBL] [Abstract][Full Text] [Related]
3. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion.
Kuhn H; Gietzen FH; Schäfers M; Freick M; Gockel B; Strunk-Müller C; Jachmann E; Schober O
Eur Heart J; 1999 Dec; 20(24):1808-17. PubMed ID: 10581139
[TBL] [Abstract][Full Text] [Related]
4. Visualization of transcoronary ablation of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: a comparison between cardiac MRI, invasive measurements and echocardiography.
Sohns C; Sossalla S; Schmitto JD; Jacobshagen C; Raab BW; Obenauer S; Maier LS
Clin Res Cardiol; 2010 Jun; 99(6):359-68. PubMed ID: 20503122
[TBL] [Abstract][Full Text] [Related]
5. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy.
Gietzen FH; Leuner CJ; Raute-Kreinsen U; Dellmann A; Hegselmann J; Strunk-Mueller C; Kuhn HJ
Eur Heart J; 1999 Sep; 20(18):1342-54. PubMed ID: 10462469
[TBL] [Abstract][Full Text] [Related]
6. Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry.
Kuhn H; Seggewiss H; Gietzen FH; Boekstegers P; Neuhaus L; Seipel L
Z Kardiol; 2004 Jan; 93(1):23-31. PubMed ID: 14740238
[TBL] [Abstract][Full Text] [Related]
7. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.
Kuhn H; Lawrenz T; Lieder F; Leuner C; Strunk-Mueller C; Obergassel L; Bartelsmeier M; Stellbrink C
Clin Res Cardiol; 2008 Apr; 97(4):234-43. PubMed ID: 18071624
[TBL] [Abstract][Full Text] [Related]
8. [Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy].
Gao YC; Li Y; Han ZH; Zhang XL; Zhao H; Jiang TY
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):333-6. PubMed ID: 17711659
[TBL] [Abstract][Full Text] [Related]
9. Myocardial perfusion and metabolism after transcoronary ablation of septum hypertrophy (TASH) in hypertrophic obstructive cardiomyopathy.
Lerch H; Schäfers M; Gietzen F; Schäfers K; Kuwert T; Kuhn H; Schober O
Nuklearmedizin; 1997 Sep; 36(6):218-22. PubMed ID: 9380540
[TBL] [Abstract][Full Text] [Related]
10. Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
Lawrenz T; Kuhn H
Z Kardiol; 2004 Jun; 93(6):493-9. PubMed ID: 15252744
[TBL] [Abstract][Full Text] [Related]
11. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
[TBL] [Abstract][Full Text] [Related]
12. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
13. The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy.
Samardhi H; Walters DL; Raffel C; Rateesh S; Harley C; Burstow D; Pohlner P; Aroney C
Catheter Cardiovasc Interv; 2014 Feb; 83(2):270-7. PubMed ID: 23873660
[TBL] [Abstract][Full Text] [Related]
14. [Safety and efficacy comparison of myocardial contrast enhancement-guided and angio-pressure-guided transcoronary ablation of septal hypertrophy for patients with hypertrophic obstructive cardiomyopathy].
Gao YC; Li Y; Wu XS; Jia CQ; Jiang TY
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):540-3. PubMed ID: 17711715
[TBL] [Abstract][Full Text] [Related]
15. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy.
Lawrenz T; Lieder F; Bartelsmeier M; Leuner C; Borchert B; Meyer zu Vilsendorf D; Strunk-Mueller C; Reinhardt J; Feuchtl A; Stellbrink C; Kuhn H
J Am Coll Cardiol; 2007 Jun; 49(24):2356-63. PubMed ID: 17572252
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular longitudinal systolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a long-term follow-up study focused on speckle tracking echocardiography.
Sommer A; Poulsen SH; Mogensen J; Thuesen L; Egeblad H
Eur J Echocardiogr; 2010 Dec; 11(10):883-8. PubMed ID: 20667848
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
[TBL] [Abstract][Full Text] [Related]
18. Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions.
Gietzen FH; Leuner CJ; Obergassel L; Strunk-Mueller C; Kuhn H
Circulation; 2002 Jul; 106(4):454-9. PubMed ID: 12135945
[TBL] [Abstract][Full Text] [Related]
19. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy - 8 years follow up.
Sathyamurthy I; Nayak R; Oomman A; Subramanyan K; Kalarical MS; Mao R; Ramachandran P
Indian Heart J; 2014; 66(1):57-63. PubMed ID: 24581097
[TBL] [Abstract][Full Text] [Related]
20. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Seggewiss H; Faber L; Ziemssen P
Cardiol Rev; 1999; 7(6):316-23. PubMed ID: 11208243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
